Ayala Pharmaceuticals, Inc.(ADXS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ADXS Ayala Pharmaceuticals, Inc.

已收盘 11-22 16:00:00 EST 延时

{"stockData":{"symbol":"ADXS","market":"US","secType":"STK","nameCN":"Ayala Pharmaceuticals, Inc.","latestPrice":0.027,"timestamp":1732309200000,"preClose":0.027,"halted":0,"volume":4040,"delay":15,"floatShares":18100900,"shares":42593900,"eps":-7.986625,"marketStatus":"已收盘","marketStatusCode":5,"change":0,"latestTime":"11-22 16:00:00 EST 延时","open":0.027,"high":0.027,"low":0.027,"amount":109.08,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-7.986625,"exchange":"EXPERT","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1732525200000},"adr":0,"adjPreClose":0.027,"volumeRatio":4.595086},"requestUrl":"/m/hq/s/ADXS","defaultTab":"news","newsList":[{"id":"2484607148","title":"美国OTC市场Advaxis, Inc.盘中异动 早盘快速下跌74.31%报0.027美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484607148","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484607148?lang=zh_cn&edition=full","pubTime":"2024-11-20 22:45","pubTimestamp":1732113944,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日22时45分，美国OTC市场Advaxis, Inc.股票出现异动，股价急速下跌74.31%。美国OTC市场Advaxis, Inc.股票所在的生物技术行业中，整体涨幅为0.18%。美国OTC市场Advaxis, Inc.公司简介：Ayala Pharmaceuticals Inc是一家处于临床阶段的肿瘤学公司，专注于开发和商业化针对罕见和侵袭性癌症患者的小分子疗法，主要是在基因界定的患者人群中。该公司目前的候选产品组合AL101和AL102目标是利用γ-分泌酶抑制剂异常激活Notch途径。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120224544971a7b1c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120224544971a7b1c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADXS","BK4139","ADXSD"],"gpt_icon":0},{"id":"2484679084","title":"美国OTC市场Advaxis, Inc.盘中异动 早盘大幅拉升289.26%报0.105美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484679084","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484679084?lang=zh_cn&edition=full","pubTime":"2024-11-18 22:46","pubTimestamp":1731941165,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日22时46分，美国OTC市场Advaxis, Inc.股票出现波动，股价急速上涨289.26%。截至发稿，该股报0.105美元/股，成交量1780股，换手率0.00%，振幅289.26%。美国OTC市场Advaxis, Inc.股票所在的生物技术行业中，整体跌幅为0.19%。美国OTC市场Advaxis, Inc.公司简介：Ayala Pharmaceuticals Inc是一家处于临床阶段的肿瘤学公司，专注于开发和商业化针对罕见和侵袭性癌症患者的小分子疗法，主要是在基因界定的患者人群中。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822460595be48c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822460595be48c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ADXSD","ADXS"],"gpt_icon":0},{"id":"2483022798","title":"美国OTC市场Advaxis, Inc.盘中异动 股价大涨250.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483022798","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483022798?lang=zh_cn&edition=full","pubTime":"2024-11-14 22:46","pubTimestamp":1731595563,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日22时46分，美国OTC市场Advaxis, Inc.股票出现波动，股价大幅上涨250.33%。美国OTC市场Advaxis, Inc.股票所在的生物技术行业中，整体跌幅为0.43%。美国OTC市场Advaxis, Inc.公司简介：Ayala Pharmaceuticals Inc是一家处于临床阶段的肿瘤学公司，专注于开发和商业化针对罕见和侵袭性癌症患者的小分子疗法，主要是在基因界定的患者人群中。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111422460395be2d01&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111422460395be2d01&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADXSD","ADXS","BK4139"],"gpt_icon":0},{"id":"2483054246","title":"美国OTC市场Advaxis, Inc.盘中异动 临近收盘股价大涨11.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483054246","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483054246?lang=zh_cn&edition=full","pubTime":"2024-11-13 04:58","pubTimestamp":1731445081,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日04时58分，美国OTC市场Advaxis, Inc.股票出现异动，股价大幅上涨11.11%。美国OTC市场Advaxis, Inc.股票所在的生物技术行业中，整体跌幅为1.07%。美国OTC市场Advaxis, Inc.公司简介：Ayala Pharmaceuticals Inc是一家处于临床阶段的肿瘤学公司，专注于开发和商业化针对罕见和侵袭性癌症患者的小分子疗法，主要是在基因界定的患者人群中。该公司目前的候选产品组合AL101和AL102目标是利用γ-分泌酶抑制剂异常激活Notch途径。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111304580295be1c9e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111304580295be1c9e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADXSD","ADXS","BK4139"],"gpt_icon":0},{"id":"2482734838","title":"美国OTC市场Advaxis, Inc.股价重挫74.31% 市值跌85.46万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482734838","media":"市场透视","labels":["Business Data"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482734838?lang=zh_cn&edition=full","pubTime":"2024-11-11 23:52","pubTimestamp":1731340321,"startTime":"0","endTime":"0","summary":"北京时间2024年11月11日23时52分，美国OTC市场Advaxis, Inc.股票出现异动，股价急速下跌74.31%。美国OTC市场Advaxis, Inc.股票所在的生物技术行业中，整体跌幅为0.04%。美国OTC市场Advaxis, Inc.公司简介：Ayala Pharmaceuticals Inc是一家处于临床阶段的肿瘤学公司，专注于开发和商业化针对罕见和侵袭性癌症患者的小分子疗法，主要是在基因界定的患者人群中。该公司目前的候选产品组合AL101和AL102目标是利用γ-分泌酶抑制剂异常激活Notch途径。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111123520195be11b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111123520195be11b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"Business Data","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADXS","BK4139","ADXSD"],"gpt_icon":0},{"id":"2481102603","title":"美国OTC市场Advaxis, Inc.盘中异动 早盘快速拉升288.54%报0.105美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481102603","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481102603?lang=zh_cn&edition=full","pubTime":"2024-11-08 22:46","pubTimestamp":1731077195,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日22时46分，美国OTC市场Advaxis, Inc.股票出现波动，股价急速上涨288.54%。美国OTC市场Advaxis, Inc.股票所在的生物技术行业中，整体涨幅为0.44%。美国OTC市场Advaxis, Inc.公司简介：Ayala Pharmaceuticals Inc是一家处于临床阶段的肿瘤学公司，专注于开发和商业化针对罕见和侵袭性癌症患者的小分子疗法，主要是在基因界定的患者人群中。该公司目前的候选产品组合AL101和AL102目标是利用γ-分泌酶抑制剂异常激活Notch途径。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110822463595bdefee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110822463595bdefee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADXSD","BK4139","ADXS"],"gpt_icon":0},{"id":"2477408368","title":"美国OTC市场Advaxis, Inc.盘中异动 急速上涨112.96%报0.058美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477408368","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477408368?lang=zh_cn&edition=full","pubTime":"2024-10-23 00:59","pubTimestamp":1729616341,"startTime":"0","endTime":"0","summary":"北京时间2024年10月23日00时59分，美国OTC市场Advaxis, Inc.股票出现波动，股价大幅上涨112.96%。美国OTC市场Advaxis, Inc.股票所在的生物技术行业中，整体跌幅为1.45%。美国OTC市场Advaxis, Inc.公司简介：Ayala Pharmaceuticals Inc是一家处于临床阶段的肿瘤学公司，专注于开发和商业化针对罕见和侵袭性癌症患者的小分子疗法，主要是在基因界定的患者人群中。该公司目前的候选产品组合AL101和AL102目标是利用γ-分泌酶抑制剂异常激活Notch途径。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102300590195bbb90a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102300590195bbb90a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADXS","ADXSD","BK4139"],"gpt_icon":0},{"id":"2477866683","title":"美国OTC市场Advaxis, Inc.盘中异动 股价大涨289.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477866683","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477866683?lang=zh_cn&edition=full","pubTime":"2024-10-21 21:46","pubTimestamp":1729518375,"startTime":"0","endTime":"0","summary":"北京时间2024年10月21日21时46分，美国OTC市场Advaxis, Inc.股票出现波动，股价大幅上涨289.26%。美国OTC市场Advaxis, Inc.股票所在的生物技术行业中，整体跌幅为0.46%。美国OTC市场Advaxis, Inc.公司简介：Ayala Pharmaceuticals Inc是一家处于临床阶段的肿瘤学公司，专注于开发和商业化针对罕见和侵袭性癌症患者的小分子疗法，主要是在基因界定的患者人群中。该公司目前的候选产品组合AL101和AL102目标是利用γ-分泌酶抑制剂异常激活Notch途径。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410212146159f53ff54&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410212146159f53ff54&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADXSD","ADXS","BK4139"],"gpt_icon":0},{"id":"2474627955","title":"美国OTC市场Advaxis, Inc.股价重挫74.31% 市值跌85.46万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2474627955","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474627955?lang=zh_cn&edition=full","pubTime":"2024-10-10 00:34","pubTimestamp":1728491641,"startTime":"0","endTime":"0","summary":"北京时间2024年10月10日00时34分，美国OTC市场Advaxis, Inc.股票出现波动，股价大幅下跌74.31%。美国OTC市场Advaxis, Inc.股票所在的生物技术行业中，整体涨幅为0.11%。美国OTC市场Advaxis, Inc.公司简介：Ayala Pharmaceuticals Inc是一家处于临床阶段的肿瘤学公司，专注于开发和商业化针对罕见和侵袭性癌症患者的小分子疗法，主要是在基因界定的患者人群中。该公司目前的候选产品组合AL101和AL102目标是利用γ-分泌酶抑制剂异常激活Notch途径。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241010003401959b41f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241010003401959b41f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADXSD","ADXS","BK4139"],"gpt_icon":0},{"id":"2473833734","title":"美国OTC市场Advaxis, Inc.股价飙升17.43% 市值涨2.34万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2473833734","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473833734?lang=zh_cn&edition=full","pubTime":"2024-10-08 00:13","pubTimestamp":1728317626,"startTime":"0","endTime":"0","summary":"北京时间2024年10月08日00时13分，美国OTC市场Advaxis, Inc.股票出现波动，股价快速上涨17.43%。美国OTC市场Advaxis, Inc.股票所在的生物技术行业中，整体跌幅为0.38%。美国OTC市场Advaxis, Inc.公司简介：Ayala Pharmaceuticals Inc是一家处于临床阶段的肿瘤学公司，专注于开发和商业化针对罕见和侵袭性癌症患者的小分子疗法，主要是在基因界定的患者人群中。该公司目前的候选产品组合AL101和AL102目标是利用γ-分泌酶抑制剂异常激活Notch途径。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241008001346a1deb0df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241008001346a1deb0df&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADXSD","ADXS","BK4139"],"gpt_icon":0},{"id":"2472248995","title":"美国OTC市场Advaxis, Inc.盘中异动 急速上涨72.22%报0.047美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472248995","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472248995?lang=zh_cn&edition=full","pubTime":"2024-10-02 22:28","pubTimestamp":1727879280,"startTime":"0","endTime":"0","summary":"北京时间2024年10月02日22时28分，美国OTC市场Advaxis, Inc.股票出现波动，股价大幅拉升72.22%。截至发稿，该股报0.047美元/股，成交量2930股，换手率0.01%，振幅0.00%。美国OTC市场Advaxis, Inc.股票所在的生物技术行业中，整体跌幅为0.88%。美国OTC市场Advaxis, Inc.公司简介：Ayala Pharmaceuticals Inc是一家处于临床阶段的肿瘤学公司，专注于开发和商业化针对罕见和侵袭性癌症患者的小分子疗法，主要是在基因界定的患者人群中。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410022228019f25417d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410022228019f25417d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADXSD","BK4139","ADXS"],"gpt_icon":0},{"id":"2472376578","title":"美国OTC市场Advaxis, Inc.股价重挫74.31% 市值跌85.46万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472376578","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472376578?lang=zh_cn&edition=full","pubTime":"2024-10-01 21:46","pubTimestamp":1727790382,"startTime":"0","endTime":"0","summary":"北京时间2024年10月01日21时46分，美国OTC市场Advaxis, Inc.股票出现异动，股价快速下挫74.31%。美国OTC市场Advaxis, Inc.股票所在的生物技术行业中，整体跌幅为0.10%。美国OTC市场Advaxis, Inc.公司简介：Ayala Pharmaceuticals Inc是一家处于临床阶段的肿瘤学公司，专注于开发和商业化针对罕见和侵袭性癌症患者的小分子疗法，主要是在基因界定的患者人群中。该公司目前的候选产品组合AL101和AL102目标是利用γ-分泌酶抑制剂异常激活Notch途径。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410012146229f235189&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410012146229f235189&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADXS","BK4139","ADXSD"],"gpt_icon":0},{"id":"2471319385","title":"美国OTC市场Advaxis, Inc.股价重挫42.18% 市值跌48.51万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2471319385","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2471319385?lang=zh_cn&edition=full","pubTime":"2024-09-30 21:45","pubTimestamp":1727703922,"startTime":"0","endTime":"0","summary":"北京时间2024年09月30日21时45分，美国OTC市场Advaxis, Inc.股票出现异动，股价快速下跌42.18%。美国OTC市场Advaxis, Inc.股票所在的生物技术行业中，整体跌幅为0.05%。美国OTC市场Advaxis, Inc.公司简介：Ayala Pharmaceuticals Inc是一家处于临床阶段的肿瘤学公司，专注于开发和商业化针对罕见和侵袭性癌症患者的小分子疗法，主要是在基因界定的患者人群中。该公司目前的候选产品组合AL101和AL102目标是利用γ-分泌酶抑制剂异常激活Notch途径。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024093021452398e39d80&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024093021452398e39d80&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ADXSD","ADXS"],"gpt_icon":0},{"id":"2470758025","title":"美国OTC市场Advaxis, Inc.股价上涨28.57% 市值涨32.86万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470758025","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470758025?lang=zh_cn&edition=full","pubTime":"2024-09-26 22:36","pubTimestamp":1727361361,"startTime":"0","endTime":"0","summary":"北京时间2024年09月26日22时36分，美国OTC市场Advaxis, Inc.股票出现异动，股价急速上涨28.57%。美国OTC市场Advaxis, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。美国OTC市场Advaxis, Inc.公司简介：Ayala Pharmaceuticals Inc是一家处于临床阶段的肿瘤学公司，专注于开发和商业化针对罕见和侵袭性癌症患者的小分子疗法，主要是在基因界定的患者人群中。该公司目前的候选产品组合AL101和AL102目标是利用γ-分泌酶抑制剂异常激活Notch途径。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240926223602957f91d6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240926223602957f91d6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ADXSD","ADXS"],"gpt_icon":0},{"id":"2470268614","title":"美国OTC市场Advaxis, Inc.盘中异动 快速拉升5.00%报0.021美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470268614","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470268614?lang=zh_cn&edition=full","pubTime":"2024-09-25 21:46","pubTimestamp":1727271992,"startTime":"0","endTime":"0","summary":"北京时间2024年09月25日21时46分，美国OTC市场Advaxis, Inc.股票出现波动，股价大幅上涨5.00%。美国OTC市场Advaxis, Inc.股票所在的生物技术行业中，整体跌幅为0.16%。美国OTC市场Advaxis, Inc.公司简介：Ayala Pharmaceuticals Inc是一家处于临床阶段的肿瘤学公司，专注于开发和商业化针对罕见和侵袭性癌症患者的小分子疗法，主要是在基因界定的患者人群中。该公司目前的候选产品组合AL101和AL102目标是利用γ-分泌酶抑制剂异常激活Notch途径。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409252146329f15f4e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409252146329f15f4e0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADXS","BK4139","ADXSD"],"gpt_icon":0},{"id":"2468340684","title":"美国OTC市场Advaxis, Inc.（ADXS.us）盘中异动 下午盘快速拉升5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2468340684","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468340684?lang=zh_cn&edition=full","pubTime":"2024-09-20 03:16","pubTimestamp":1726773361,"startTime":"0","endTime":"0","summary":"北京时间2024年09月20日03时16分，美国OTC市场Advaxis, Inc.股票出现波动，股价急速拉升5.00%。美国OTC市场Advaxis, Inc.股票所在的生物技术行业中，整体涨幅为1.57%。美国OTC市场Advaxis, Inc.公司简介：Ayala Pharmaceuticals Inc是一家处于临床阶段的肿瘤学公司，专注于开发和商业化针对罕见和侵袭性癌症患者的小分子疗法，主要是在基因界定的患者人群中。该公司目前的候选产品组合AL101和AL102目标是利用γ-分泌酶抑制剂异常激活Notch途径。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409200316019f0862ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409200316019f0862ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADXS","ADXSD","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.advaxis.com","description":"Advaxis, Inc.最初于1987年6月5日在科罗拉多州以Great Expectation公司的名义成立。过去，该公司一直是一个没有任何业务的空壳上市公司，直到2004年11月12日通过一份于同年8月25日签署的股份交换和重整协议收购了一家名为Advaxis的特拉华州公司。Advaxis是一家处于临床开发阶段的生物科技公司，专注于研究Lm-LLO免疫疗法以治疗癌症和传染病，并将该疗法开发并商业化。该免疫疗法主要基于李斯特菌的利用，通过生物工程将抗原加工。","exchange":"EXPERT","name":"Ayala Pharmaceuticals, Inc.","nameEN":"Ayala Pharmaceuticals, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Ayala Pharmaceuticals, Inc.(ADXS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Ayala Pharmaceuticals, Inc.(ADXS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Ayala Pharmaceuticals, Inc.,ADXS,Ayala Pharmaceuticals, Inc.股票,Ayala Pharmaceuticals, Inc.股票老虎,Ayala Pharmaceuticals, Inc.股票老虎国际,Ayala Pharmaceuticals, Inc.行情,Ayala Pharmaceuticals, Inc.股票行情,Ayala Pharmaceuticals, Inc.股价,Ayala Pharmaceuticals, Inc.股市,Ayala Pharmaceuticals, Inc.股票价格,Ayala Pharmaceuticals, Inc.股票交易,Ayala Pharmaceuticals, Inc.股票购买,Ayala Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Ayala Pharmaceuticals, Inc.(ADXS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Ayala Pharmaceuticals, Inc.(ADXS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}